The results showed that RESV suppresses the metastatic potential of human osteosarcomas through transcriptional and epigenetic regulation of MMP-2 by respectively inhibiting CREB-DNA-binding activity and upregulating miR-328. Here, CREB1 is linked to osteosarcoma.